Product Information
DEPAKOTE DR 125 MG TABLET is a brand product labeled by AbbVie Inc., priced at $2.0537 per EA under NDC 00074732513. Its NADAC has been published 171 times since Mar 22, 2023.
The High Outlier badge above means this manufacturer's average price in the Divalproex Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
125 mg/1
Manufacturer
AbbVie Inc.NDC
00074732513
Classification
Brand
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DIVALPROEX SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA018723On Market Since
3/10/1983
Pharmacological Classes
Price Statistics
The NADAC for DEPAKOTE DR 125 MG TABLET has been published 171 times since Mar 22, 2023, and over the history we have for it it has risen 14.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0537 per EA |
|---|---|
| All-time high | $2.0566 (Jun 10, 2026) |
| All-time low | $1.7901 (Mar 22, 2023) |
| 52-week high | $2.0566 |
| 52-week low | $1.9551 |
| Median price | $1.8796 |
| Average price | $1.9088 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 171 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEPAKOTE DR 125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEPAKOTE DR 125 MG TABLET, manufactured by AbbVie Inc., is $2.0537 per EA (NDC 00074732513), effective Jun 24, 2026.
How has the price of DEPAKOTE DR 125 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEPAKOTE DR 125 MG TABLET has risen 14.7%. It has been tracked across 171 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for DEPAKOTE DR 125 MG TABLET?
Since Mar 22, 2023, the NADAC for DEPAKOTE DR 125 MG TABLET has ranged from a low of $1.7901 (Mar 22, 2023) to a high of $2.0566 (Jun 10, 2026), with a median of $1.8796 per EA.
Are there cheaper alternatives to DEPAKOTE DR 125 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DIVALPROEX SOD DR 125 MG TAB, is $0.0541 per EA — about 97% below DEPAKOTE DR 125 MG TABLET.
Who manufactures DEPAKOTE DR 125 MG TABLET?
DEPAKOTE DR 125 MG TABLET (NDC 00074732513) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification